Herantis Pharma Oyj Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Other Revenue	0.18	-	-	-	-	Upgrade
Revenue	0.18	-	-	-	-	Upgrade
Gross Profit	0.18	-	-	-	-	Upgrade
Selling, General & Admin	1.92	1.49	1.74	2.65	2.25	Upgrade
Other Operating Expenses	4.65	3.54	-1.89	5.18	7.5	Upgrade
Operating Expenses	6.57	5.03	-0.15	7.99	12.46	Upgrade
Operating Income	-6.4	-5.03	0.15	-7.99	-12.46	Upgrade
Interest Expense	-0.36	-0	-0.02	-0.07	-0.06	Upgrade
Interest & Investment Income	-	0.05	0.04	0	0	Upgrade
Other Non Operating Income (Expenses)	0.13	0.04	0.11	-1.26	-0.24	Upgrade
EBT Excluding Unusual Items	-6.62	-4.94	0.28	-9.32	-12.77	Upgrade
Pretax Income	-6.62	-4.94	0.28	-9.32	-12.77	Upgrade
Net Income	-6.62	-4.94	0.28	-9.32	-12.77	Upgrade
Net Income to Common	-6.62	-4.94	0.28	-9.32	-12.77	Upgrade
Shares Outstanding (Basic)	24	20	17	15	10	Upgrade
Shares Outstanding (Diluted)	24	20	17	15	10	Upgrade
Shares Change (YoY)	17.27%	17.25%	17.34%	43.59%	38.03%	Upgrade
EPS (Basic)	-0.28	-0.24	0.02	-0.64	-1.25	Upgrade
EPS (Diluted)	-0.28	-0.24	0.02	-0.64	-1.25	Upgrade
Free Cash Flow	-6.1	-6.55	-4.64	-8.94	-9.93	Upgrade
Free Cash Flow Per Share	-0.26	-0.33	-0.27	-0.61	-0.97	Upgrade
Gross Margin	100.00%	-	-	-	-	Upgrade
Operating Margin	-3592.70%	-	-	-	-	Upgrade
Profit Margin	-3719.10%	-	-	-	-	Upgrade
Free Cash Flow Margin	-3424.16%	-	-	-	-	Upgrade
EBITDA	-	-	-	-7.99	-12.46	Upgrade
EBIT	-6.4	-5.03	0.15	-7.99	-12.46	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.